Ou M

ORCID: 0000-0001-7263-6647 · 5 papers in corpus
other 2026
Journal of translational medicine ·doi:10.1186/s12967-026-07903-x

BACKGROUND: Immune tolerance breakdown at the maternal-fetal interface is implicated in unexplained recurrent pregnancy loss (URPL), but the interplay between T cell hyperactivation and dendritic cells (DCs)-mediated signaling remains poorl…

observational 2025
Human Reproduction ·doi:10.1093/humrep/deaf042

STUDY QUESTION: What are the unrecognized risk factors for recurrent implantation failure (RIF) as defined in the ESHRE recommendation? SUMMARY ANSWER: Anti-Müllerian hormone (AMH) is the strongest predictor for RIF, followed by chronic en…

other 2023
Wiener klinische Wochenschrift ·doi:10.1007/s00508-023-02219-y

The well-known impact of ovarian endometriosis on female quality of life and the established role of lncRNA LINC01465 in ovarian cancer pathogenesis have been extensively documented; however, the relationship between LINC01465 and ovarian e…

lab-animal 2021
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-021-02277-z

BACKGROUND: Decidualization is critical for embryo implantation and the success of pregnancy; however, the mechanisms underlying this process remain largely unknown. MATERIALS AND METHODS: In the present study, RNA sequencing was used to d…

lab-animal 2014
The AAPS journal ·doi:10.1208/s12248-013-9559-2

Mifepristone (RU486) is marketed and used widely by women as an abortifacient, and experimentally for psychotic depression and anticancer treatments. After administration, metapristone is found to be the most predominant metabolite of mifep…